• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts
    • MPR: Breakthrough Products Series
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Job Board
    • Leadership in Medtech
    • Manufacturer Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
    • DeviceTalks
  • Coronavirus: Live updates
Home » Device tax: Repeal efforts claim another Democrat, nay-sayers cry foul

Device tax: Repeal efforts claim another Democrat, nay-sayers cry foul

May 29, 2012 By MassDevice staff

MassDevice.com coverage of the medical device tax

Rep. Bill Owens (D-N.Y.) earlier this month joined a growing cadre of Democrats who have signed their name to a medical device tax repeal bill that’s set to hit the House floor for a vote in coming weeks.

Rep. Erik Paulsen’s (R-Minn.) repeal measure, which is more than a year in the making, aims to kill the 2.3% levy that will affect all U.S. sales of medical devices starting January 2013, raising more than $30 billion over 10 years.

Owens was among the latest to sign his name to the bill, which may get a vote on the House floor as early as this week, but he did so with little fanfare. His office issued no statements, despite the fact that he is 1 of about a dozen House Democrats to cross the aisle and co-sponsor the measure.

Repeal efforts haven’t managed to muster much support from Senate Democrats either. Not a single one has signed on to the companion version of the repeal measure in that chamber.

The conflict surrounding the repeal measure is heightened on both sides by Democrats who don’t want to challenge any aspect of ACA ahead of the Supreme Court ruling and Republicans who want whole-sale repeal of the healthcare reform law rather than a piecemeal approach.

"A lot of my colleagues, including leadership, felt that once we had a vote for repeal [of the Affordable Care Act], that that was adequate, and some of the more conservative members of the House, didn’t want to pick and choose," Paulsen told MassDevice.com in February. "There are some Democratic members who have not signed on to the repeal bill because they’re a little nervous about acknowledging that the healthcare law they may have voted for isn’t perfect."

"They’re more inclined to vote for it if they get the opportunity to vote on the floor, rather than sign their name on it and deal with a sort of push-back among some of their own base," Paulsen added.

The GOP-led effort has at least one opponent in the left-leaning Center on Budget & Policy Priorities, which issued a report earlier this year discounting med-tech industry warnings about the tax as "misinformation and exaggerated claims."

Device makers and advocates have warned that the burden imposed by the impending levy could push jobs overseas, shut down small businesses and hamper innovation.

"Contrary to lobbyists’ talking points, the tax will not cause manufacturers to shift production overseas, since it applies to both imported and domestically produced medical devices, and it exempts U.S. exports," according to the CBPP report. "Nor is the tax likely to have much effect on innovation in the medical device industry; in fact, health reform as a whole may well spur innovation by promoting more cost-effective ways of delivering healthcare."

Repealing the tax would add to the deficit and undercut health reform efforts by encouraging other health industries to fight revenue-raising provisions as well, according to the report.

The political pinball has been heating up ahead of the much-anticipated House vote on the medical device tax repeal measure.

The partisan furor picked up in Massachusetts, home to a large swath of device makers including Boston Scientific (NYSE:BSX) and Abiomed (NSDQ:ABMD), as the National Republican Congressional Committee earlier this month castigated Rep. Niki Tsongas (D-Mass.) over the tax and her "commitment to her party’s limitless spending addiction and job-killing agenda."

The statement appears on the website for Tsongas challenger Tom Weaver (R), who hopes to take the 5th district seat Tsongas has held since 2007.

The political fray in the Bay State got a little murkier last month when Harvard professor and Senate hopeful Elizabeth Warren (D) called for the repeal of the medical device tax in  an exclusive op-ed for MassDevice.com.

Warren’s actions became a launching point for GOPers looking to pressure their across-the-aisle opponents into making a move.

Congressional candidate Richard Tisei (R-Mass.) called on fellow Bay State Rep. Jon Tierney (D-Mass.) to lend his name to the tax repeal bill, calling Tierney’s continued support for the levy "unacceptable" and "a clear example of how Tierney’s economic policies directly hurt the voters" in his district."

"John Tierney is even to the left of Elizabeth Warren on the 2.3% excise tax on medical device manufacturers," Tisei said in prepared remarks. "John Tierney should go talk with the employees of the medical device industry in our district and see what they think of this destructive tax on Massachusetts jobs."

Filed Under: News Well Tagged With: U.S. Congress, U.S. House of Representatives

In case you missed it

  • FDA clears Neurolief’s noninvasive neuromod tech to treat migraines
  • Could this hydrogel repair a broken heart?
  • Virta Health touts study of treatment preventing progression to Type 2 diabetes
  • Philips, DiA partner on AI-based applications for ultrasound
  • Cook Medical wins FDA breakthrough device designation for next-gen endovascular graft
  • FDA grants breakthrough nod to Anuncia’s cerebral spinal fluid treatment
  • Varian CEO Dow Wilson to retire after merger with Siemens Healthineers
  • Medtronic touts results of cardiac resynchronization therapy trial
  • Ambu single-use endoscope wins Frost & Sullivan innovation award
  • Abbott researchers help discover a clue to an HIV cure
  • Q BioMed wins federal contract for bone cancer drug
  • Report: Biden to announce partnership for Merck to make J&J’s COVID-19 vaccine
  • FDA accepts New Drug Application for Eyenovia pupil dilation tech
  • Axonics, Micro Systems Technologies partners to make rechargeable SNM device
  • Component Testing & Analysis: How to Gain Deeper Insights with a Universal Testing System
  • SeaSpine ticks up on 6.2% sales growth in Q4, reports losses
  • Boston Scientific completes Preventice buy, divests BTG Pharmaceutical business

RSS From Medical Design & Outsourcing

  • Could this hydrogel repair a broken heart?
    European researchers have developed an injectable hydrogel that they say could help repair and prevent further damage to the heart muscle after a heart attack. The therapeutic effect of multiple injections of this hydrogel into the cardiac tissue was assessed during the first preclinical study of its kind, demonstrating its efficacy for cardiac tissue remodeling… […]
  • How EtO plants can avoid lawsuits, cope with stricter regulation
    If EtO industry actors take certain targeted steps now, they can minimize legal exposure, more efficiently manage litigation and be better situated for compliance once new federal regulations are established. Karen Cullinane, Goldberg Segalla The use of ethylene oxide (EtO) to sterilize medical devices came under renewed scrutiny after the Environmental Protection Agency concluded in… […]
  • FDA authorizes Q-Collar to help protect athletes’ brains
    The FDA announced today that it authorized the Q-Collar made by Q30 Sports Science for protecting the brain during sports activities. Q30 Sports Science’s Q-Collar is a C-shaped collar worn around the neck designed to apply compressive force to the neck and increase blood volume to help reduce movement of the brain within the cranial… […]
  • The top 7 medtech CEO quotes on COVID-19, one year later
    The latest earnings season has provided insights into the future of medtech in the COVID-19 landscape and what certain sectors are seeing as vaccines start to roll out. Since the start of the pandemic, 113.1 million COVID-19 cases have been reported worldwide, according to Johns Hopkins University School of Medicine. The U.S. leads the world… […]
  • Pfizer wins FDA nod to store COVID vaccine at normal freezer temps
    The FDA announced today that it is allowing undiluted, frozen vials of the Pfizer-BioNTech COVID-19 vaccine to be transported and stored for up to two weeks at conventional temperatures commonly found in pharmaceutical freezers. The decision should allow for wider distribution of the vaccine to sites that do not have ultra-low temperature freezers. Pfizer asked… […]
  • 8 drug delivery innovations you need to know
    The drug delivery space has seen plenty of innovation over the years, and there are no signs of that slowing down any time soon. Improvements upon established technologies like insulin delivery devices and inhalers have been presented by some, while others have unlocked new ways of delivering drugs through a variety of means. Among the… […]
  • Hoffer Plastics gains MedAccred certification again
    Injection molding company Hoffer Plastics (South Elgin, Ill.) announced that it has received the MedAccred re-certification from not-for-profit medtech audit provider MedAccred. MedAccred is a supply-chain oversight program of the Performance Review Institute. It conducts critical-process audits for its member OEMs to ensure their suppliers adhere to global regulations and requirements, and helps reduce the number… […]
  • UK passes post-Brexit medical device regulation
    The U.K. has enacted a new law governing medical devices and drugs, with a focus on patient safety. The Medicines and Medical Devices Act, introduced in July 2020, establishes the position of commissioner for patient safety to respond to public and patient complaints and concerns about drugs and medical devices. The law was necessitated by… […]
  • Integrated Polymer Solutions acquires IRP Group
    Integrated Polymer Solutions (“IPS”), a portfolio company of Arcline Investment Management, announced this week that it has acquired IRP Group. IRP designs and manufacturers elastomeric sealing components from its facilities in Southern California. Founded in 1999, the company is focused on the Class I and II medical device market as well as the aerospace &… […]
  • Interpower debuts plugs in new colors
    Interpower announced that its NEMA 5-20 hospital-grade plugs for use in North America now come in molded colors of clear, black or gray on 10-foot lengths of flexible cord. These molded plugs complement the company’s NEMA 5-20 hand-wired hospital-grade plugs. The North American 18A hospital-grade power cord on 14 AWG SJT cable and North American… […]
  • Portescap motors gain certification
    Portescap announced that its slotless brushless DC motors for respirators have received ISO 13485:2016 certification. Expanding on ISO 9001, this standard contains specific requirements for parts traceability and risk management activities throughout the design and development stages. It also requires process and software validations at defined intervals. Independent risk management and quality compliance firm DNV… […]

Leave a Reply Cancel reply

You must be logged in to post a comment.

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Tweets by @MassDevice
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion

MASSDEVICE

Subscribe to MassDevice
Advertise with us
About
Contact us

Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2021 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS